Wellcome Trust — Full Portfolio
9 tracked investments · listed companies and verified rows first
CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions.
Deep TechHealthtechMedical DevicesHouston, US
John Criscione(Director)inWilliam Altman(Executive Officer, Director)inDennis Robins(Director)Boris Leschinsky(Executive Officer)Clarice Motter(Executive Officer)Keith Svagerko(Executive Officer)
Co-investorsHouston Angel NetworkKeiretsu ForumTMC Venture FundCowtown AngelsHarvard Business School Alumni Angels of Greater New YorkAggie Angel Network+1 more
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)in
Co-investorsO2h VenturesWren CapitalCambridge Angels groupEMV CapitalMartlet CapitalStoic VC+1 more
Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform.
BiotechHealthtechMedical DevicesLyon, FR
Alexandre Le Vert(Executive Chairman & Co-Founder)Dr Florence Nicolas(Chief Scientific Officer & Co-Founder)Dr Fergal Hill(Co-founder)
Co-investorsStart CapitalCAP HORN VC
TAE Technologies develops hydrogen-boron (aneutronic) fusion power using a beam-driven Field-Reversed Configuration reactor design, aiming to deliver utility-scale fusion electricity to the grid in the early 2030s.
CleantechDeep TechEnergyFoothill Ranch, US
Norman Rostoker(Co-founder)Michl Binderbauer(CEO)inCedric Burgher(Chief Financial Officer)in
Co-investorsNew Enterprise Associates (NEA)Chevron Technology VenturesCapital FactoryUpVentures CapitalVenrockRUSNANO
Ineffable is an AI research lab focused on building superintelligence through the reinforcement learning paradigm, emphasizing learning from experience in the environment rather than from human data.
AI & Machine LearningDeep TechLondon, GB
David Silver(Founder)inAlexandre Laterre(Co-Founder)inChris Apps(Founder)in
BoardAlfred Lin(Director (Sequoia Capital))Ravi Mhatre(Director (Lightspeed))
Co-investorsEQT VenturesFlying Fish VenturesIndex VenturesLightspeed Venture PartnersSequoia CapitalBond Capital Management+6 more
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante Health VenturesSante Ventures
Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.
ConsumerMedia & Entertainment
Co-investorsAndera PartnersBrace PharmaNew Leaf Venture PartnersOrbiMed
EnergySan Diego, US
James E. Levine(Chief Executive Officer and President)James Astwood(Senior Vice President of Product Management)James Butler(Vice President of Legal Affairs and Intellectual Property)Thomas Willardson(Chief Financial Officer)
BoardSteven Goldby(Director)Eric Luo(Director)
Co-investorsARCH Venture PartnersVenrock
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.